Posts by: Charles Moore

News

Two scientists at Dartmouth College in Hanover, New Hampshire, are pioneering the first experimental use of algorithms employing structure-based molecular modeling with the objective of optimizing deimmunized drug candidates. The work ... Read more

August 22, 2014August 22, 2014

Natural Killer Immune Cell Discovery Could Help To Block Cancer Spread

News

A team of researchers from the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia have revealed the critical importance of highly specialized immune cells, called natural killer cells, ... Read more

August 20, 2014August 20, 2014

CEL-SCI Expands Global Phase III Immunotherapy Head and Neck Cancer Trial into Centre Hospitalier Universitaire de Quebec in Canada

News

Vienna, Virginia based CEL-SCI Corporation has announced that its global Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection) has added ... Read more

July 30, 2014July 30, 2014

Cancer Researchers Identify Mutations as Targets of Effective Melanoma Immunotherapy

News

A new study published in the American Association for Cancer Research journal Clinical Cancer Research demonstrates that recognition of unique cancer mutations appeared to be responsible for complete cancer regressions ... Read more